TUBERCULOSIS, MULTIDRUG-RESISTANT
Clinical trials for TUBERCULOSIS, MULTIDRUG-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS, MULTIDRUG-RESISTANT trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, MULTIDRUG-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New All-Oral cocktail could tame Drug-Resistant TB
Disease control OngoingThis study tests a combination of five oral drugs (bedaquiline, delamanid, levofloxacin, linezolid, and clofazimine) for treating multidrug-resistant tuberculosis (MDR-TB). About 271 participants aged 12 and older will receive the regimen for 16, 24, 32, or 40 weeks to find the s…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase: PHASE2 • Sponsor: Boston University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New TB test could speed up detection of Drug-Resistant strains
Diagnosis OngoingThis study evaluates a new PCR test (Bioneer Q-RFIA kit) for quickly and accurately detecting tuberculosis (TB) and resistance to key antibiotics. About 2,350 adults with TB symptoms will provide samples to see how well the test works compared to standard methods. The goal is to …
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated May 12, 2026 13:43 UTC